DFX Intelligence

NeuroPace

Venture-backed companyneuropace.com

The NeuroPace RNS System is the only FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity and provides EEG data that can help improve patient care.

As of 2026-09-17 · the latest observation of this company; each round carries its own date

Rounds on record: 0

Public company. Publicly listed (NPCE); its private filings are not venture rounds.

Ask DFX about this View relationships Financing history Investors Ownership and outcomes

As of 2026-09-17 · the latest observation of this company; each round carries its own date

What matters now

Public
observed
Initial public offering (seen on or before Sep 16, 2026).
seen on or before Sep 16, 2026 · A later owner ends or changes the venture chapter: new decision makers, new lenders, returns for the investors on record.
Factpress and portfolio pagesFor Investors, acquirers, lenders, service providersOwnership and outcomes →
2 investors
named
2 investors on record.
The investors already on the cap table shape who leads the next round.
Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →

Relationship network

2 connected entities2 observed investment records

From announced rounds, SEC Form D filings (investors, directors, officers and placement agents) and investors' own portfolio pages.

NeuroPace

Reading the network

Capital provider

Venture relationships are not scored. Each line names its claim: a round led or joined, a board seat or a filing that names the firm, a listing on a portfolio page (dated by when DFX saw it, never by when the investment was made), a disclosed LP commitment, or a co-investor pair counted from observed participations. Observed means a named source says so; Derived means DFX counted it from observed rows; Inferred means a match that may be wrong.

Ask DFX about this network

Who are the investors and board members of NeuroPace?

Drawing the relationship network…

Facts

Year of incorporation: unknown
Revenue range (Form D): unknown
Rounds on record: 0
Disclosed raised: unknownsum of rounds with a disclosed amount only
Named investors: 2

Financing history

0 rounds

No dated round yet.

Investors on record

2 edges

Accelmed Partners II Management, LLC portfolio listing Fact accelmed.com
Sprig Equity Management, LLC portfolio listing Fact sprigequity.com

Ownership and outcomes

1 on record, from the private equity graph and exit reports

Initial public offering · already an investor on record
seen on or before Sep 16, 20262 venture investors on record at exitFactsprigequity.com
“NeuroPace: went public by IPO on or before 2026-09-16 (no date published), per Sprig Equity Management, LLC's portfolio page”

Credit relationships

none on record

No lender position matched to this company.

People

0 officers, 0 directors

No officer or director on record.

Timeline

1 event

seen on or beforeSep 16, 2026
NeuroPace: went public by IPO on or before 2026-09-16 (no date published), per Sprig Equity Management, LLC's portfolio page
IPO Fact Firm website

Evidence

6 observations

Every observation on this company

Description: Sep 15, 2026 Fact Company website
Listed on portfolio page: Accelmed Partners II Management, LLC Sep 16, 2026 Fact Firm website
Listed on portfolio page: Sprig Equity Management, LLC Sep 16, 2026 Fact Firm website
Listed on portfolio page: Accelmed Partners II Management, LLC Sep 15, 2026 Fact Firm website
Website status: ok Sep 15, 2026 Fact Company website
Site title: Sep 15, 2026 Fact Company website

Record history

1 dated event on the change ledger, latest first

Ipo
2026-09-16source

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.